Literature DB >> 16550921

Molecular pathomechanism of distal myopathy with rimmed vacuoles.

I Nishino1, May Christine V Malicdan, K Murayama, I Nonaka, Y K Hayashi, S Noguchi.   

Abstract

Distal myopathy with rimmed vacuoles (DMRV) and hereditary inclusion body myopathy (HIBM) are now known to be the same disease and are caused by mutations in tile GNE gene that encodes a bifunctional protein with two enzymatic activities: UDP-GlcNAc2-epimerase (GNE) and ManNAc kinase (MNK). GNE catalyzes the rate-limiting step in the sialic acid biosynthesis and MNK catalyzes the next step. So far, we have found homozygous or compound heterozygous mutations in 55 unrelated Japanese DMRV patients. Among them, c.1714G>C (p.V572L) mutation is the most common, accounting for 57% of the mutant alleles. The same mutation was recently identified also in Korean DMRV patients, raising the possibility of the presence of a common founder. We have also found that cardiac involvement is not very rare and is found in 18% of patients, albeit degree of severity widely varies; in some patients, it can result in sudden death. The length of time when patients become non ambulatory is diverse. The severity of clinical symptoms also varies widely, as evidenced by the presence of an asymptomatic homozygote harboring of p.D176V, the second most common mutation among Japanese patients. Patients' fibroblasts and myotubes are hyposialylated and this hyposialylation can be recovered by adding GNE metabolite, ManNAc, or sialic acid per se, NeuAc. Accordingly, the sialylation status in the skeletal muscle tissue is also greatly altered especially in fibers with rimmed vacuoles, suggesting the tight association between hyposialylation and the formation of rimmed vacuoles. However, we still do not know why hyposialylation leads to the formation of rimmed vacuoles. To further elucidate the pathomechanism and to develop a therapy of DMRV, we need to produce mouse model mouse for this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16550921

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  14 in total

1.  Clinical features, lectin staining, and a novel GNE frameshift mutation in hereditary inclusion body myopathy.

Authors:  N C Voermans; M Guillard; R Doedée; M Lammens; M Huizing; G W Padberg; R A Wevers; B G van Engelen; D J Lefeber
Journal:  Clin Neuropathol       Date:  2010 Mar-Apr       Impact factor: 1.368

2.  Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy.

Authors:  Anna Cho; May Christine; V Malicdan; Miho Miyakawa; Ikuya Nonaka; Ichizo Nishino; Satoru Noguchi
Journal:  Hum Mol Genet       Date:  2017-08-15       Impact factor: 6.150

Review 3.  Metabolic manipulation of glycosylation disorders in humans and animal models.

Authors:  Hudson H Freeze; Vandana Sharma
Journal:  Semin Cell Dev Biol       Date:  2010-04-02       Impact factor: 7.727

4.  A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy, a sugar-deficient myopathy: a review.

Authors:  May Christine V Malicdan; Satoru Noguchi; Ichizo Nishino
Journal:  Ther Adv Neurol Disord       Date:  2010-03       Impact factor: 6.570

Review 5.  Mutation update for GNE gene variants associated with GNE myopathy.

Authors:  Frank V Celeste; Thierry Vilboux; Carla Ciccone; John Karl de Dios; May Christine V Malicdan; Petcharat Leoyklang; John C McKew; William A Gahl; Nuria Carrillo-Carrasco; Marjan Huizing
Journal:  Hum Mutat       Date:  2014-08       Impact factor: 4.878

6.  Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy.

Authors:  May Christine V Malicdan; Satoru Noguchi; Tomoharu Tokutomi; Yu-ichi Goto; Ikuya Nonaka; Yukiko K Hayashi; Ichizo Nishino
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

7.  Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model.

Authors:  May Christine V Malicdan; Satoru Noguchi; Yukiko K Hayashi; Ikuya Nonaka; Ichizo Nishino
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

8.  Quantitative hydrophilic interaction chromatography-mass spectrometry analysis of N-acetylneuraminic acid and N-acetylmannosamine in human plasma.

Authors:  Yifan Shi; Xin Xu; Meng Fang; Michael Zhang; Yinghe Li; Brad Gillespie; Selwyn Yorke; Nora Yang; John C McKew; William A Gahl; Marjan Huizing; Nuria Carrillo-Carrasco; Amy Qiu Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-07-17       Impact factor: 3.205

Review 9.  Perspectives on distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy: contributions from an animal model. Lack of sialic acid, a central determinant in sugar chains, causes myopathy?

Authors:  M C V Malicdan; S Noguchi; I Nishino
Journal:  Acta Myol       Date:  2007-12

Review 10.  Sialic acid utilization.

Authors:  Norbert Sprenger; Peter I Duncan
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.